These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 25691102)

  • 1. Production of immune response mediators by HT-29 intestinal cell-lines in the presence of Bifidobacterium-treated infant microbiota.
    Arboleya S; Bahrami B; Macfarlane S; Gueimonde M; Macfarlane GT; de los Reyes-Gavilán CG
    Benef Microbes; 2015; 6(4):543-52. PubMed ID: 25691102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro evaluation of the impact of human background microbiota on the response to Bifidobacterium strains and fructo-oligosaccharides.
    Arboleya S; Salazar N; Solís G; Fernández N; Gueimonde M; de los Reyes-Gavilán CG
    Br J Nutr; 2013 Dec; 110(11):2030-6. PubMed ID: 23721811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactic acid bacteria and bifidobacteria attenuate the proinflammatory response in intestinal epithelial cells induced by Salmonella enterica serovar Typhimurium.
    Carey CM; Kostrzynska M
    Can J Microbiol; 2013 Jan; 59(1):9-17. PubMed ID: 23391223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunology and probiotic impact of the newborn and young children intestinal microflora.
    Bezirtzoglou E; Stavropoulou E
    Anaerobe; 2011 Dec; 17(6):369-74. PubMed ID: 21515397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-time monitoring of HT29 epithelial cells as an in vitro model for assessing functional differences among intestinal microbiotas from different human population groups.
    Nogacka AM; Ruas-Madiedo P; Gómez E; Solís G; Fernández N; Suárez M; Suárez A; Salazar N; de Los Reyes-Gavilán CG; Gueimonde M
    J Microbiol Methods; 2018 Sep; 152():210-216. PubMed ID: 30006229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2 Ingestion Induces a Less Inflammatory Cytokine Profile and a Potentially Beneficial Shift in Gut Microbiota in Older Adults: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.
    Spaiser SJ; Culpepper T; Nieves C; Ukhanova M; Mai V; Percival SS; Christman MC; Langkamp-Henken B
    J Am Coll Nutr; 2015; 34(6):459-69. PubMed ID: 25909149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of intestinal microbiota modulation ability of Bifidobacterium strains in in vitro fecal batch cultures from preterm neonates.
    Arboleya S; Salazar N; Solís G; Fernández N; Hernández-Barranco AM; Cuesta I; Gueimonde M; de los Reyes-Gavilán CG
    Anaerobe; 2013 Feb; 19():9-16. PubMed ID: 23154045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long Term Development of Gut Microbiota Composition in Atopic Children: Impact of Probiotics.
    Rutten NB; Gorissen DM; Eck A; Niers LE; Vlieger AM; Besseling-van der Vaart I; Budding AE; Savelkoul PH; van der Ent CK; Rijkers GT
    PLoS One; 2015; 10(9):e0137681. PubMed ID: 26378926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of Bifidobacterium breve on immune mediators and proteome of HT29 cells monolayers.
    Sánchez B; González-Rodríguez I; Arboleya S; López P; Suárez A; Ruas-Madiedo P; Margolles A; Gueimonde M
    Biomed Res Int; 2015; 2015():479140. PubMed ID: 25793196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of probiotics on faecal microbiota and genotoxic activity of faecal water in patients with atopic dermatitis: a randomized, placebo-controlled study.
    Roessler A; Forssten SD; Glei M; Ouwehand AC; Jahreis G
    Clin Nutr; 2012 Feb; 31(1):22-9. PubMed ID: 21963389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of maternal bifidobacteria and the mode of delivery on Bifidobacterium microbiota in infants.
    Sirilun S; Takahashi H; Boonyaritichaikij S; Chaiyasut C; Lertruangpanya P; Koga Y; Mikami K
    Benef Microbes; 2015; 6(6):767-74. PubMed ID: 26322546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius.
    O'Hara AM; O'Regan P; Fanning A; O'Mahony C; Macsharry J; Lyons A; Bienenstock J; O'Mahony L; Shanahan F
    Immunology; 2006 Jun; 118(2):202-15. PubMed ID: 16771855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunostimulatory effect of faecal Bifidobacterium species of breast-fed and formula-fed infants in a peripheral blood mononuclear cell/Caco-2 co-culture system.
    Pozo-Rubio T; Mujico JR; Marcos A; Puertollano E; Nadal I; Sanz Y; Nova E
    Br J Nutr; 2011 Oct; 106(8):1216-23. PubMed ID: 21736809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the synbiotic properites of human milk oligosaccharides and Bifidobacterium longum subsp. infantis in vitro and in humanised mice.
    Musilova S; Modrackova N; Hermanova P; Hudcovic T; Svejstil R; Rada V; Tejnecky V; Bunesova V
    Benef Microbes; 2017 Apr; 8(2):281-289. PubMed ID: 28116928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbial and immune faecal determinants in infants hospitalized with COVID-19 reflect bifidobacterial dysbiosis and immature intestinal immunity.
    Gutiérrez-Díaz I; Sanz-Martinez M; Castro AM; Rodríguez-Belvís MV; Carreira N; Jiménez S; Mangas C; Queralt M; Herrador M; Martín-Masot R; Ferrer P; Navas-López VM; Espín B; Leis R; Díaz JJ; Delgado S
    Eur J Pediatr; 2023 Oct; 182(10):4633-4645. PubMed ID: 37555973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bifidobacterium microbiota and parameters of immune function in elderly subjects.
    Ouwehand AC; Bergsma N; Parhiala R; Lahtinen S; Gueimonde M; Finne-Soveri H; Strandberg T; Pitkälä K; Salminen S
    FEMS Immunol Med Microbiol; 2008 Jun; 53(1):18-25. PubMed ID: 18336547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bifidobacterial strains shared by mother and child as source of probiotics.
    Peirotén A; Arqués JL; Medina M; Rodríguez-Mínguez E
    Benef Microbes; 2018 Feb; 9(2):231-238. PubMed ID: 29488411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal Immunomodulation and Shifts on the Gut Microbiota of BALB/c Mice Promoted by Two
    Nogacka AM; Oddi S; Salazar N; Reinheimer JA; Gueimonde M; Vinderola G; de Los Reyes-Gavilán CG
    Biomed Res Int; 2019; 2019():2323540. PubMed ID: 31119156
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of probiotic strains on the microbiota of the Simulator of the Human Intestinal Microbial Ecosystem (SHIME).
    Alander M; De Smet I; Nollet L; Verstraete W; von Wright A; Mattila-Sandholm T
    Int J Food Microbiol; 1999 Jan; 46(1):71-9. PubMed ID: 10050686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast milk: a source of bifidobacteria for infant gut development and maturation?
    Gueimonde M; Laitinen K; Salminen S; Isolauri E
    Neonatology; 2007; 92(1):64-6. PubMed ID: 17596738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.